RESUMEN
In this work, a hybrid nanocomposite material (PUC2@rGO) was prepared by integrating our previously developed Zn-MOF (PUC2) with reduced graphene oxide (rGO) through the wet impregnation method. The characterization of PUC2@rGO was performed using various analytical techniques, including FTIR, PXRD, FE-SEM, HR-TEM, XPS, zeta potential, and time-resolved FL spectroscopy. Our investigation primarily focused on assessing the composite's capability to detect water pollutants. Notably, PUC2@rGO demonstrated remarkable selectivity and sensitivity towards Pb2+ and Cu2+ ions via fluorescence quenching, exhibiting low detection limits and high quenching constant values. Spectroscopic analysis revealed that electron transfer from PUC2@rGO (donor) to the metal ions (acceptor) resulted in the observed quenching effect induced by Pb2+ and Cu2+ ions. Time-resolved fluorescence studies of PUC2@rGO before and after adding Pb2+ and Cu2+ ions confirmed dynamic quenching, further affirming strong interactions between PUC2@rGO and the targeted metal ions. These findings highlight PUC2@rGO's potential for efficiently detecting heavy metal pollutants in water.
RESUMEN
Advanced Glycation End-products (AGEs), with their prolonged half-life in the human body, are emerging as potent diagnostic indicators. Early intervention studies, focusing on AGE cross-link breakers, have shown encouraging results in heart failure patients, paving the way for disease progression monitoring and therapy effectiveness evaluation. AGEs are the byproducts of a non-enzymatic reaction where sugars interact with proteins, lipids, and nucleic acids. These compounds possess the power to alter numerous biological processes, ranging from disrupting molecular conformation and promoting cross-linking to modifying enzyme activity, reducing clearance, and impairing receptor recognition. The damage inflicted by AGEs through the stimulation of intracellular signaling pathways is associated with the onset of chronic diseases across various organ systems. This review consolidates the characteristics of AGEs and the challenges posed by their expression in diverse physiological and pathological states. Furthermore, it highlights the clinical relevance of AGEs and the latest research breakthroughs aimed at reducing AGE accumulation.
Asunto(s)
Epigénesis Genética , Productos Finales de Glicación Avanzada , Neoplasias , Humanos , Productos Finales de Glicación Avanzada/metabolismo , Neoplasias/metabolismo , Neoplasias/patología , Neoplasias/genética , Animales , GlicosilaciónRESUMEN
Nymphaea rubra (N. rubra) flowers are prevalent in subtropical regions for both dietary and traditional medicinal purposes, attributing to their beneficial properties in supporting overall health. This study first time provides descriptions of the antidiabetic and dyslipidemic properties employing STZ induced high fat diet fed diabetic rats and inhibition of α-amylase enzyme activity first by in vitro analyses, followed by a confirmatory in silico study to create a stronger biochemical rationale. Furthermore, in 3 T3-L1 cells, this extract promoted the suppression of adipogenesis. GC-MS investigation of the ethyl acetate fraction of ethanolic extract of N. rubra flowers revealed the presence of marker compounds of N. rubra, Nuciferine, and Apomorphine, which were the focus of molecular docking studies. The acquired concentrations of Nuciferine (22.39%) and 10, 11-dimethoxy-Apomorphine (1.47%) were detected. Together with other alkaloids identified by GC-MS analysis from this extract, mechanistically suggested that it might be caused by the synergistic impact of these bioactive chemicals. Molecular docking has been done to check the binding affinities of various isolated phytochemicals with HPAA, the dose-response effect of 100 mg/kg and 250 mg/kg of flower extract after 30 days showed a significant effect on body weight, food, water intake, serum insulin, FBG, OGTT, lipid profile, glycated haemoglobin, liver and kidney function test. Kidney histopathology results show a significant effect. These findings offer a strong foundation for the potential application of the ethyl acetate fraction of ethanolic extract from Nymphaea rubra flowers and its bioactive constituent in an in vivo system for the treatment and control of diabetes and its associated condition dyslipidemia.
Asunto(s)
Diabetes Mellitus Experimental , Flores , Hipoglucemiantes , Simulación del Acoplamiento Molecular , Nymphaea , Fitoquímicos , Extractos Vegetales , Ratas Wistar , Animales , Flores/química , Hipoglucemiantes/farmacología , Hipoglucemiantes/química , Diabetes Mellitus Experimental/tratamiento farmacológico , Ratas , Fitoquímicos/farmacología , Fitoquímicos/aislamiento & purificación , Ratones , Masculino , Extractos Vegetales/farmacología , Extractos Vegetales/química , Nymphaea/química , Células 3T3-L1 , Adipogénesis/efectos de los fármacos , alfa-Amilasas/antagonistas & inhibidores , alfa-Amilasas/metabolismo , Estructura Molecular , Dieta Alta en GrasaRESUMEN
Nanotechnology is considered a successful approach for cancer diagnosis and treatment. Preferentially, cancer cell recognition and drug targeting via nano-delivery system include the penetration of anticancer agents into the cell membrane to damage the cancer cell by protein modification, DNA oxidation, or mitochondrial dysfunction. The past research on nano-delivery systems and their target has proven the beneficial achievement in a malignant tumor. Modern perceptions using inventive nanomaterials for cancer management have been offered by a multifunctional platform based on various nano-carriers with the probability of imaging and cancer therapy simultaneously. Emerging nano-delivery systems in cancer therapy still lack knowledge of the biological functions behind the interaction between nanoparticles and cancer cells. Since the potential of engineered nanoparticles addresses the various challenges, limiting the success of cancer therapy subsequently, it is a must to review the molecular targeting of a nano-delivery system to enhance the therapeutic efficacy of cancer. This review focuses on using a nano-delivery system, an imaging system, and encapsulated nanoparticles for cancer therapy.
Asunto(s)
Antineoplásicos , Nanomedicina , Neoplasias , Humanos , Neoplasias/tratamiento farmacológico , Nanomedicina/métodos , Antineoplásicos/uso terapéutico , Antineoplásicos/administración & dosificación , Nanopartículas/química , Sistemas de Liberación de Medicamentos , Animales , Portadores de Fármacos/químicaRESUMEN
Diabetes is a metabolic illness that increases protein glycosylation in hyperglycemic conditions, which can have an impact on almost every organ system in the body. The role of vitamin D in the etiology of diabetes under RAGE (receptor for advanced glycation end products) stress has recently received some attention on a global scale. Vitamin D's other skeletal benefits have generated a great deal of research. Vitamin D's function in the development of type 1 and type 2 diabetes is supported by the discovery of 1,25 (OH)2D3 and 1-Alpha-Hydroylase expression in immune cells, pancreatic beta cells, and several other organs besides the bone system. A lower HBA1c level, metabolic syndrome, and diabetes mellitus all seems to be associated with vitamin D insufficiency. Most of the cross-sectional and prospective observational studies that were used to gather human evidence revealed an inverse relationship between vitamin D level and the prevalence or incidence of elevated HBA1c in type 2 diabetes. Several trials have reported on the impact of vitamin D supplementation for glycemia or incidence of type 2 diabetes, with varying degrees of success. The current paper examines the available data for a relationship between vitamin D supplementation and HBA1c level in diabetes and discusses the biological plausibility of such a relationship.